Information Journal Paper
APA:
Copy. (2017). MiR-181a inhibits nonsmall cell lung cancer cell proliferation by targeting CDK1. CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS, 20(4), 539-546. SID. https://sid.ir/paper/727752/en
Vancouver:
Copy. MiR-181a inhibits nonsmall cell lung cancer cell proliferation by targeting CDK1. CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS[Internet]. 2017;20(4):539-546. Available from: https://sid.ir/paper/727752/en
IEEE:
Copy, “MiR-181a inhibits nonsmall cell lung cancer cell proliferation by targeting CDK1,” CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS, vol. 20, no. 4, pp. 539–546, 2017, [Online]. Available: https://sid.ir/paper/727752/en